References
- Meunier F. Fungal infections in the compromised host. Clinical approach to infection in the compromised host, R H Rubin, L S Young. Plenum Publishing Corporation, New York 1988; 193–220
- Musial C A, Cockerill F R, Roberts G D. Fungal infection of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev 1988; 1: 349–364
- Rippon J W. Zygomycosis. Medical mycology3rd ed. WB Saunders, Philadelphia, London 1988; 681–713
- Weems J J, Davis B J, Tablan O C, Kaufman L, Martone W J. Construction activity: An independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 1987; 8: 71–75
- Lehrer R I. Mucormycosis. UCLA Conference. Arch Intern Med 1980; 93: 93–108
- Holczinger L. Histochemischer Nachweis freier Fettsäuren. Acta Histochem (Jena) 1959; 8: 167–175
- Shadomy S, Espinel‐Ingroff A, Cartwright R Y. Laboratory studies with antifungal agents: susceptibility tests and bioassays. Manual of clinical microbiology4th ed., E H Lennette, A Balows, W J Hausler, H J Shadomy. Am Soc Microbiol, Washington, DC 1985; 992–993
- Nahas E. Control of lipase production by Rhizopus oligosporus under various growth conditions. J Gen Microbiol 1988; 134: 227–233
- Meyer R D. Agents of mucormycosis and related species. Principles and practice of infectious disease2nd ed., G L Mandell, R G Douglas, J E Bennett. Wiley Medical Publication, New York 1985; 1452–1456
- Vainrub B, Macareno A, Mandel S. Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med 1988; 84: 546–548
- Fisher J, Tuazon C U, Geelhoed G W. Mucormycosis in transplant patients. Am Surg 1980; 46: 315–322
- Lamour C, Baruchel S, Bertrand Y, Bonnet M, Montagne J ‐P, Vuthien H, Balquet P. Mucormycose et diabète au cours d'un leucémie aiguë. Arch Fr Pediatr 1988; 45: 267–269
- Meyers B R, Wormser G, Hirschmann S Z, Blitzer A. Rhinocerebral mucormycosis. Premortem diagnosis and therapy. Arch Intern Med 1979; 139: 557–560
- Polo J R, Luño J, Menarguez C, Gallego E, Robles R, Hernandez P. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1989; 12: 237–239
- Kaplan A H, Poza-Juncal E, Shapiro R, Stapleton J T. Cure of mucormycosis in a renal transplant patient receiving ciclosporin with maintenance of immunosuppression. Am J Nephrol 1988; 8: 139–142
- Morduchowicz G, Shmueli D, Shapira Z, Cohen S L, Yussim A, Block C S, Rosenfeld J B, Pitlik S D. Rhinocerebral mucormycosis in renal transplant patients: report of three cases and review of the literature. Rev Infect Dis 1986; 8: 441–446
- Barnert J, Behr W, Reich H. An ampotericin B‐resistant case of rhinocerebral mucormycosis. Infection 1985; 13: 134–136
- Petranyi G, Ryder N S, Stütz A. Allylamine derivatives: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984; 224: 1239–1241
- Shadomy S, Espinel‐Ingroff A, Gebhart R J. In vitro studies with SF86–327, a new orally active allylamine derivative. Sabouraudia: J Med Vet Mycol 1985; 23: 125–132
- R A Fromtling. JR Prous Science Publishers. 1987; 461–470
- Rosenberger R S, West B C, King J W. Case report survival from sinoorbital mucormycosis due to Rhizopus rhizopodiformis. Am J Med Sci 1983; 286: 25–30
- West B C, Kwon‐Chung K J, King J W, Grafton W D, Rohr M S. Inguinal abscess caused by Rhizopus rhizopodiformis. Successful treatment with surgery and amphotericin B. J Clin Microbiol 1983; 18: 1384–1387
- Tolkoff‐Rubin N E, Rubin R H. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. Transplant Proc 1986; 18: 168–173